Notices

Current Mpox Vaccine Inventory Expiring Soon

Current Mpox Vaccine Inventory Expiring Soon

All current mpox vaccine provided by PDPH will expire on October 31, 2024. Please make sure to dispose of the vaccine and mark your inventory as wasted in PhilaVax as appropriate. Use this Mpox Vaccine Wastage Guide for assistance.

As a reminder, be sure to accept all pending transfers in PhilaVax. If this is not completed, it affects the ability of your site to submit a correct, completed, and closed reconciliation. Please use this Accepting Shipments Guidance for assistance.

After Expiration

While our JYNNEOS vaccine availability is currently limited, we recommend providers prioritize vaccinating the uninsured and underinsured population, as other mechanisms exist to purchase vaccine for private payers.

Vaccines can be purchased through:

HRSA grant and Ryan White HIV/AIDS Program (RWHAP) funding may be used to purchase JYNNEOS vaccine
340B Prime Vendor Program offers reduced prices to eligible providers sites (e.g., FQHCs)

Insurance Reimbursement

Medicaid/Medicare – full coverage for all beneficiaries within ACIP recommended populations.
Commercial Insurance:
- Expect private plans to fully cover within ACIP recommendations.
- Plans obligated to cover one year following ACIP recommendation.

Retail Pharmacy Vaccine Access

Appointments are now available at several pharmacy chains (e.g., CVS, RiteAid, Walgreens).

View the CDC mpox vaccine locator!

RSV Ordering Update

Beginning Monday, October 28, 2024, all RSV orders will require current temperature files and a current reconciliation due on the day the order is placed.

Routine Immunizations, RSV, and COVID-19 vaccine orders: Current temperature data and reconciliation due the same day as the order.

Flu vaccine orders: Current temperature data and reconciliation due within two weeks of the 1st seasonal order. After the initial order, the current reconciliation is due every 60 days.

Help Us Improve Our Trainings

Are our trainings helpful for your clinic? Let us know how we can improve and share what you’d like to see from us in the future.

Many of you may be familiar with our provider training videos, which are available on our YouTube page. To improve the quality of our trainings, we are asking that you complete this short survey.

Take the Quick Survey

Training Videos

Online Ordering & Clinic Tools Training
Required Vaccine Webinars

Register for the 2024 PIC Conference!

Spots are filling up fast — register today! We’re excited to see you at the Philadelphia Immunization Coalition’s Fall 2024 Conference.

Our speakers will include Dr. Andrew Kroger (CDC) and Dr. Paul Offit (CHOP), among others.

Topics covered will include COVID-19, RSV, flu, hepatitis B updates, community outreach, vaccine hesitancy, PDPH updates, and more. View the full agenda here!

This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of Penn State College of Medicine and Philadelphia Immunization Coalition. Penn State College of Medicine is accredited by the ACCME to provide continuing medical education for physicians.

Penn State College of Medicine designates this live activity for a maximum of 4.5 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Registration is now open. Use the button below to register.

Tickets will be $40 and include breakfast, all day coffee, and a wonderful hot lunch.

Hope to see you there!

Register

Event Details

When: Tuesday, October 29, 2024
Time: 8 a.m. – 3:30 p.m.
Where: College of Physicians at 19 South 22nd Street, Philadelphia, PA 19103

Reach out to angel.brice@phila.gov with any questions. Learn more about the Philadelphia Immunization Coalition.

Beyfortus Open Ordering Now Available

VFC providers are now welcome to order Beyfortus as needed. The CDC has released a limited amount in each wave, so we encourage sites to order early. Orders may be adjusted to ensure equity among patient populations.

Dosages:

RSV comes in two dosages:

50 mg
100 mg

Both dosages are administered as an intramuscular injection with a single-dose, pre-filled syringe and should be ordered to be properly administered by weight.

Eligible Patients

Infants aged <8 months born during or entering their first RSV season
- 1 dose of nirsevimab (50 mg for infants <5 kg and 100 mg for infants ≥5 kg)
- Do not give two doses of the 50 mg product in place of the 100 mg product
Children aged 8-19 months who are at increased risk of severe RSV disease and entering their second RSV season
- 200 mg nirsevimab, administered by two 100 mg syringes

For questions or concerns, reach out to Victor Obeck at victor.obeck@phila.gov or our Ordering Team at DPHproviderhelp@phila.gov.

Mpox Vaccine: Holiday Notice

Mpox vaccine deliveries will be paused during the week of Indigenous Peoples’ Day, October 14-18, 2024.

Ordering will remain open this week until Wednesday, October 9, 2024 at 5:00 p.m.

The last delivery for mpox vaccine will be on Thursday, October 10, 2024. Remember to submit your temperatures to tempcheck@phila.gov and complete a reconciliation of vaccine on hand for your order to be approved.

Deliveries for mpox vaccine will resume on the week of October 21, 2024. If you have any questions, please contact Danny Reed at danny.reed@phila.gov.

Click the button below to submit your order request for mpox vaccine.

Mpox Vaccine Request Form

2024 – 2025 COVID-19 Vaccines Available to Order

As a reminder, the federally funded Bridge Access Program (BAP) ended on August 12, 2024. Last season’s 2023- 2024 COVID-19 vaccines are now unauthorized and should not be administered.

If you have not done so already, remove all 2023 – 2024 COVID-19 vaccines from storage units and return any unused product. Use this guide to assist you.

The Immunization Program has been awarded limited funds to allow providers previously enrolled in the BAP to order a small quantity of updated 2024 – 2025 Spikevax (Moderna) to vaccinate uninsured and underinsured adults at their practice.

Please note that these doses are limited. Large orders may be reduced due to limited supply. You can order 2024 – 2025 COVID-19 vaccine today. Upload a complete reconciliation of your current COVID-19 inventory and temperature files with every order.

If you have questions regarding your site’s allocations, contact Nyandra McFadden at nyandra.mcfadden@phila.gov.

We value your efforts in vaccinating underinsured and uninsured adults and want to express our gratitude for your continued participation in our programs.

New Flu and COVID-19 Products Available

New Flu and COVID-19 Products Available

VFC providers can now order:

2024-2025 Novavax COVID-19 products for 12 years and older
Flucelvax (Sequirus)
FluMist (AstraZeneca)

Make sure that your EHR/EMR is set up to report this year’s COVID-19 products.

These are the vaccines available:

When placing COVID-19 orders, please remember:

Complete a current COVID-19 reconciliation.
Submit your temperature data. Upload the CSV file into PhilaVax. Email the LTD file to tempcheck@phila.gov.

When placing flu orders, please remember:

You do not have to complete a reconciliation.
Submit your temperature data. Upload the CSV file into PhilaVax. Email the LTD file to tempcheck@phila.gov.

Training Videos: School Required Immunizations

Pennsylvania law requires all students (K-12) to be vaccinated while attending school. Students who do not have the required vaccines may be excluded from school until they receive the appropriate vaccines.

Since the 2020 school year, national coverage with state-required vaccines among kindergarten students has declined.

Work with parents and guardians to schedule vaccination appointments to help get your patients on track with immunizations.

Training Videos

We have created a series of short training videos to support your practice. The videos cover topics including school immunization requirements, the ACIP child and adolescent immunization schedule, information on specific vaccines, vaccine interval spacing, and Vaccine Adverse Event Reporting System (VAERS) reporting.

View Training Videos

Meningococcal B Vaccination: Bexsero Dosing

Meningococcal B Vaccination: Bexsero Dosing

On August 19, 2024, the Food and Drug Administration approved a new dosing schedule for GSK meningococcal B (menB) vaccine, Bexsero.

The 1 month interval between dose 1 and 2 is no longer licensed, and has been replaced by a 6 month interval between dose 1 and 2. With the new dosing schedule, if a second dose is given earlier than 6 months after the first dose, a third dose should be administered at least 4 months after the second dose.

We will issue an updated advisory after the October 2024 Advisory Committee on Immunization Practices (ACIP) meeting if they offer new guidance on how to approach adolescents that have already received Bexsero on the previously approved interval (one month between dose 1 and 2).

View the updated package insert for Bexsero dosing and schedule intervals below.

Updated Bexsero package insert

Individuals at Increased Risk

Immunocompromised people and those at high risk of menB disease should receive a 3-dose schedule with doses given at 0, 1–2, and 6-month intervals. If the second dose of a 3-dose schedule is delayed and administered 6 months or longer after the first dose, the third dose is not needed.

Additional Resources

GSK letter

MenB vaccine recommendations guide